Amyloid beta associations with connected speech in cognitively unimpaired adults.

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Kimberly D MuellerSterling Johnson

Abstract

Connected speech and language (CSL) decline has been associated with early cognitive decline, but associations between CSL and Alzheimer's disease (AD) biomarkers remain a gap in the literature. Our goal was to examine associations with amyloid beta (Aβ) and longitudinal CSL trajectories in cognitively unimpaired adults at increased AD risk. Using data from the Wisconsin Registry for Alzheimer's Prevention, CSL measures were automatically extracted from digitally recorded picture descriptions. Positron emission tomography determined Aβ status. Linear mixed effects models assessed the interaction between age and Aβ on CSL trajectories. Participants who were Aβ positive experienced more rapid decline on specific word content, when controlling for age, sex, and literacy. There were no differences between groups in lexical diversity measures over time. These results indicate that declines in connected speech may be related to preclinical AD. CSL may be a promising, inexpensive, and easy-to-collect digital cognitive marker for AD studies.

References

May 1, 1985·Brain and Language·D B HierA G Shindler
Sep 1, 1985·Journal of Speech and Hearing Research·M NicholasN Helm-Estabrooks
Dec 3, 2004·Brain : a Journal of Neurology·Peter GarrardKaralyn Patterson
Jan 11, 2005·Neurobiology of Aging·Kathryn P RileyWilliam R Markesbery
Feb 4, 2006·The Journal of the Acoustical Society of America·Jacques Koreman
Oct 20, 2007·Brain : a Journal of Neurology·Jonathan D RohrerJason D Warren
Feb 18, 2010·Language Variation and Change·Ewa JacewiczJoseph Salmons
Jun 18, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Bradley T ChristianCharles A Mistretta
Apr 15, 2011·Brain : a Journal of Neurology·Alexander DrzezgaReisa A Sperling
Nov 25, 2011·Journal of Alzheimer's Disease : JAD·Emmanuel J BarbeauMathieu Ceccaldi
Jan 12, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I P MartinsP A Stilwell
Jul 4, 2012·Neuropsychology·Sarah E PriceDiana Perre
Jan 1, 2011·Aphasiology·Brian MacwhinneyAudrey Holland
Oct 22, 2013·Brain : a Journal of Neurology·Samrah AhmedPeter Garrard
Nov 26, 2013·Neurobiology of Aging·Sterling C JohnsonMark A Sager
Feb 22, 2014·Dementia and Geriatric Cognitive Disorders·Rebecca L KoscikMark A Sager
Jul 10, 2014·Journal of Neuroinflammation·Eduardo Rigon ZimmerPedro Rosa-Neto
Oct 1, 2014·Brain : a Journal of Neurology·Hyun Kook LimHoward J Aizenstein
May 31, 2015·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Kimberly Diggle MuellerMark A Sager
May 20, 2016·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Lindsay R ClarkSterling C Johnson
Jan 13, 2018·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Sterling C JohnsonMark A Sager
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackUNKNOWN Contributors

❮ Previous
Next ❯

Software Mentioned

MOR
Computerized Language Analysis ( CLAN )
CLAN
R Core Team
Codes for the Human Analysis of Transcripts ( CHAT )
lmerTest
R

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.